TWO · 6610.TWO
TWi Biotechnology, Inc.
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
Loading market information…
TWO · 1777.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SYN-TECH Chem. & Pharm. Co., Ltd.’s forward annual dividend is NT$4.00 per share, paid annual. The forward yield is 5.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
SYN-TECH Chem. & Pharm. Co., Ltd.’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of NT$1.54. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SYN-TECH Chem. & Pharm. Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$314.27M |
| Q3 2024 | Nov 4, 2024 | NT$2.60 | NT$330.58M |
|---|
| Q2 2024 | Aug 12, 2024 | NT$2.21+274.58% vs estimate | NT$343.03M+73.25% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$17.90-NT$0.10 (-0.56%)
TWi Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
NT$54.00-NT$1.70 (-3.05%)
Sinew Pharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.47% below the high.
NT$27.95-NT$0.45 (-1.58%)
BRIM Biotechnology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.34% below the high.
NT$45.75+NT$0.55 (+1.22%)
Sagittarius Life Science Corp’s quoted price sits in the lower half of its reported 52-week range, 31.72% below the high.
NT$60.40-NT$2.10 (-3.36%)
Shine-On BioMedical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.05% below the high.
NT$29.00-NT$0.75 (-2.52%)
Apex Biotechnology Corp.’s quoted price sits in the lower half of its reported 52-week range, 15.45% below the high.
NT$83.40-NT$2.40 (-2.8%)
Syngen Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.85% below the high.
NT$28.50-NT$1.60 (-5.32%)
3D Global Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.66% below the high.
